Showing results (481-490 of 2,639) with videos related to

Sort By:
Pageof 264
Hematology (Amsterdam, Netherlands)|April 13, 2026
A survival prognostic model for high-risk myelodysplastic syndrome patients treated with decitabineYumei Liu, Haiyue Niu, Yansong Wei, et al.
Hematology (Amsterdam, Netherlands)|April 3, 2026
Temporal trends in second primary malignancies among long-term survivors of multiple myeloma across treatment eras: a population-based analysis of the SEER databaseLiling Lu, Shenglan Lin, Yating Chen, et al.
Hematology (Amsterdam, Netherlands)|June 4, 2026
Distinct clinical, molecular, and treatment response profiles in primary and secondary myelofibrosis: a single-center retrospective studyWenya Liu, Yue Ren, Yingao Liang, et al.
Hematology (Amsterdam, Netherlands)|June 19, 2023
KMT2A is targeted by miR-361-3p and modulates leukemia cell's abilities to proliferate, migrate and invadeDan Xu, Jinlong Jiang, Guangsheng He, et al.
Hematology (Amsterdam, Netherlands)|June 8, 2023
De nove Philadelphia chromosome-positive myelodysplastic syndromes with complex karyotype and p230Jinlong Ma, Jiaheng Guan, Baoan Chen
Hematology (Amsterdam, Netherlands)|July 16, 2005
Macrophages promote development of human erythroid precursors in transferrin-free culture mediumJ M Leimberg, A M Konijn, E Fibach
Hematology (Amsterdam, Netherlands)|April 1, 2026
Social determinants of health associated with multiple myeloma incidence and survival among a low-income cohort in the Southeastern U.SAnna Junkins, Wanqing Wen, Loren Lipworth, et al.
Hematology (Amsterdam, Netherlands)|April 21, 2026
In-hospital and short-term outcomes in patients with atrial fibrillation undergoing chimeric antigen receptor-T cell therapyNan Zhao, Wen Li, Qian Chen, et al.
Hematology (Amsterdam, Netherlands)|April 24, 2026
XPO1 inhibitor selinexor suppresses homologous recombination by inhibiting E2F7 nuclear export in acute myeloid leukemiaChunli Xu, Dandan Wang, Ruiqi Chen, et al.
Hematology (Amsterdam, Netherlands)|April 27, 2026
First report of a rare hemoglobin variant in the Chinese population: clinical and hematological characteristics of Hb Norton [HBA2:c.217C>G] and its impact on HbA1c testing: a case reportJian Shang, Zirui Cao, Weidong Chen, et al.
Pageof 264